Intensity Therapeutics, Inc. (INTS)
4.23
-0.02
(-0.47%)
USD |
NASDAQ |
Aug 31, 12:18
Intensity Therapeutics Price : 4.23 for Aug. 31, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 4.30 | 4.579 | 4.22 | 4.25 | 22425.00 |
| Aug 27, 2026 | 4.59 | 4.70 | 4.19 | 4.27 | 75201.00 |
| Aug 26, 2026 | 4.83 | 5.075 | 4.36 | 4.53 | 126262.0 |
| Aug 25, 2026 | 4.71 | 5.17 | 4.695 | 4.895 | 103893.0 |
| Aug 24, 2026 | 4.57 | 4.860 | 4.57 | 4.75 | 26899.00 |
| Aug 21, 2026 | 4.89 | 4.89 | 4.531 | 4.86 | 20260.00 |
| Aug 20, 2026 | 4.16 | 4.91 | 4.16 | 4.88 | 68817.00 |
| Aug 19, 2026 | 4.25 | 4.33 | 4.20 | 4.20 | 17157.00 |
| Aug 18, 2026 | 4.13 | 4.37 | 4.13 | 4.21 | 8289.00 |
| Aug 17, 2026 | 3.96 | 4.169 | 3.94 | 4.15 | 24830.00 |
| Aug 14, 2026 | 4.01 | 4.19 | 3.901 | 3.960 | 38950.00 |
| Aug 13, 2026 | 4.07 | 4.200 | 3.93 | 4.00 | 53389.00 |
| Aug 12, 2026 | 4.11 | 4.34 | 4.10 | 4.16 | 15278.00 |
| Aug 11, 2026 | 4.17 | 4.35 | 4.120 | 4.20 | 26259.00 |
| Aug 10, 2026 | 4.19 | 4.35 | 4.150 | 4.29 | 14576.00 |
| Aug 07, 2026 | 4.530 | 4.530 | 4.16 | 4.16 | 22384.00 |
| Aug 06, 2026 | 4.21 | 4.34 | 4.21 | 4.25 | 12399.00 |
| Aug 05, 2026 | 4.00 | 4.325 | 3.995 | 4.20 | 64745.00 |
| Aug 04, 2026 | 4.28 | 4.28 | 4.15 | 4.18 | 33137.00 |
| Aug 03, 2026 | 4.09 | 4.39 | 4.09 | 4.26 | 12016.00 |
| Jul 31, 2026 | 4.01 | 4.55 | 4.01 | 4.15 | 78103.00 |
| Jul 30, 2026 | 4.31 | 4.42 | 4.008 | 4.05 | 44387.00 |
| Jul 29, 2026 | 4.40 | 4.50 | 4.316 | 4.33 | 21660.00 |
| Jul 28, 2026 | 4.51 | 4.55 | 4.31 | 4.55 | 30005.00 |
| Jul 27, 2026 | 4.50 | 4.57 | 4.39 | 4.57 | 10771.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 81.66 |
| Oncolytics Biotech, Inc. | 0.8393 |
| Sangamo Therapeutics, Inc. | 0.1605 |
| Sarepta Therapeutics, Inc. | 21.10 |
| Anixa Biosciences, Inc. | 3.43 |
Price Related Metrics
| Price to Book Value | 1.352 |
| Earnings Yield | -114.2% |
| Market Cap | 12.46M |